Integra LifeSciences Unveils Plans for Oppenheimer Presentation

Author: Thomas Cooper Updated: 03-13-2025 05:33 PM

Integra LifeSciences to Present at Significant Healthcare Conference

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent name in the global medical technology arena, has announced its participation in the upcoming Oppenheimer 35th Annual Healthcare MedTech & Services Conference. Scheduled for March 17, 2025, at 10:00 AM ET, this presentation is anticipated to highlight the company's innovative approaches and contributions to the medical field.

Company Leadership to Take Center Stage

The conference will feature Mojdeh Poul, the chief executive officer, alongside Lea Knight, the chief financial officer of Integra. Their presentation aims to provide insights into the company's strategic direction and how it continues to impact patient outcomes positively. Stakeholders and interested parties can expect a detailed overview of Integra's latest advancements and future plans.

Live Webcast Available for Investors

For those unable to attend in person, a live webcast of the presentation will be accessible via the Integra LifeSciences investor relations website. This initiative reflects the company's commitment to transparency and engagement with its investors. By providing an online streaming option, Integra ensures that a wider audience can participate in this vital event.

About Integra LifeSciences: Mission and Vision

At the heart of Integra LifeSciences is the mission to restore patients' lives through innovative medical solutions. The company is dedicated to advancing treatment pathways and improving surgical outcomes, neurologic care, and regenerative treatment practices. With a diverse portfolio of high-quality brands, Integra leads the way in setting new standards within the healthcare industry.

Contact Information for Investor Relations

Integra encourages inquiries and invites discussions through its dedicated investor relations contact, Chris Ward. For any questions regarding the upcoming conference or company performance, investors can reach out via phone at (609) 772-7736 or through email for personalized assistance. The investor relations team is always ready to provide support and information as needed.

Media Inquiries Made Easy

For media-related inquiries, the designated contact is Laurene Isip. She can be reached at (609) 208-8121, ensuring that all press-related questions and communications are efficiently handled. Integra places a high priority on clear communication and remains open to media collaboration.

Integra's Commitment to Innovation

As a leader in medical technology, Integra LifeSciences is continuously focused on research and development. This commitment reflects in how the company innovates treatment options that significantly advance patient care. By investing in cutting-edge technologies and fostering a culture of innovation, Integra remains at the forefront of medical advancements.

Frequently Asked Questions

What is the main focus of Integra LifeSciences at the conference?

Integra will focus on its strategic innovations in medical technology and how it enhances patient outcomes.

Who will represent Integra at the Oppenheimer conference?

CEO Mojdeh Poul and CFO Lea Knight will represent Integra LifeSciences at the event.

Will there be a way to watch the presentation if I cannot attend?

Yes, the presentation will be available via a live webcast on the Integra investor relations website.

How does Integra LifeSciences contribute to patient care?

Integra innovates treatment pathways and offers a comprehensive portfolio to improve surgical and regenerative care.

Who can I contact for investor inquiries about Integra?

Chris Ward is the contact for investor relations, and he can be reached at (609) 772-7736.

About The Author

Hello, I'm Thomas Cooper, a financial expert and writer passionate about helping people understand and navigate the financial world. Having a solid financial background and a lot of experience, my area of expertise is simplifying difficult financial ideas into useful, understandable guidance. My goal with my writings and blog entries is to provide you the information and resources you need to make wise financial choices.

I am thrilled to contribute my ideas and engage with a lively investor community at Investors Hangout, where I recently joined the team. My mission is to make finance interesting and approachable so you may take charge of your financial future. I appreciate you coming along on this path to success and financial knowledge.

Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.